Related Experiment Videos
Clear cell sarcoma in the era of sentinel lymph node mapping
Waddah B Al-Refaie1, Mir W Ali, David Z Chu
1Department of Surgery, University of California, San Diego, California 92093, USA.
Journal of Surgical Oncology
|August 31, 2004
Summary
Clear cell sarcoma of the tendons and aponeuroses (CCSTA) is a rare cancer. Sentinel lymph node biopsy may help predict prognosis in CCSTA patients.
Area of Science:
- Oncology
- Surgical Pathology
- Soft Tissue Tumors
Background:
- Clear cell sarcoma of the tendons and aponeuroses (CCSTA) is an aggressive soft tissue neoplasm.
- CCSTA has a propensity for lymphatic metastasis, making lymph node status a critical prognostic factor.
Observation:
- This study reports on three patients diagnosed with CCSTA.
- All patients underwent simultaneous sentinel lymph node biopsy (SLNB) and tumor resection.
Findings:
- Sentinel lymph node mapping was performed in conjunction with surgical resection for CCSTA.
- The findings suggest that SLNB may offer prognostic value in managing CCSTA.
Implications:
- Sentinel lymph node biopsy could be a valuable tool for staging and predicting outcomes in clear cell sarcoma.
- Further research is warranted to validate the role of SLNB in CCSTA management and improve patient prognostication.